Cindy Jean Radavich, APRN Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 5920 N Govt Way Ste 2, Dalton Gardens, ID 83815 Phone: 208-696-4462 |
News Archive
Anti-abortion activists have "scored a victory" after a decision last week by the Obama administration to not allow the new high-risk pools in America to cover most abortions, The Associated Press reports.
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.
Wanting to replace the medical equipment for taking X-rays, the Mexican Society of Radiology (CMR) created a system of digital x-ray imaging, which replaces the traditional plaque by a solid detector, which delivers results in five seconds. Analog equipment take six minutes to develop the traditional film.
› Verified 3 days ago